FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to preparing a pharmaceutical composition in the form of a suspension for preventing and treating disturbed physiological and reparative regeneration of locomotor tissues - bone tissue and articular cartilage. Pharmaceutical compositions stimulating supporting tissue and articular cartilage regeneration contain the substance Micellate of calcium carbonate and magnesium carbonate. The studies have proved that the offered pharmaceutical compositions showed manifested reparative-regenerative action and caused no manifested general toxic action in various doses and routes of administration in experimental animals.
EFFECT: composition has no irritant action; sensibilising action is not observed; pharmaceutical compositions are effective agents for preventing and treating disturbed physiological and reparative regeneration of locomotor tissues - bone tissue and articular cartilage.
2 cl, 2 ex, 1 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION 'MYCEPHOSPHONE' FOR STIMULATION OF SUPPORTING TISSUE REGENERATION | 2010 |
|
RU2442592C1 |
PHARMACEUTICAL COMPOSITION 'MYCESLAVINE' WITH ANTI-SHOCK AND ANTI-ALLERGIC ACTION (VARIANTS) | 2010 |
|
RU2442590C1 |
PHARMACEUTICAL COMPOSITION 'MYCENORM' WITH ANTACIDIC ACTION | 2010 |
|
RU2442591C1 |
PHARMACEUTICAL COMPOSITION "MICEREBROPHON" HAVING NOOTROPIC ACTIVITY | 2010 |
|
RU2441657C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING JOINT AND BONE TISSUE DISEASES | 2013 |
|
RU2547572C2 |
COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
COMPOSITION STIMULATING REPARATIVE OSTEOGENESIS IN DOGS AND CATS | 2022 |
|
RU2785118C1 |
CALCIUM SALT AGENT FOR TREATING LOCOMOTIVE DISEASES IN HUMAN AND ANIMALS, INCLUDING BONE FRACTURES AND DISEASES ASSOCIATED WITH CALCIUM DEFICIENCY | 2010 |
|
RU2416415C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
Authors
Dates
2012-03-10—Published
2010-12-15—Filed